BioX Medical
1 / 5
The system utilizes advanced magnetic particle separation technology. By using magnetic particles as antibody carriers, they can be evenly distributed in the liquid phase reaction system, ensuring faster reaction speeds and higher efficiency.
| Feature | Specification |
|---|---|
| Model | BKI2200 |
| Throughput | 120T/H |
| Principle | Magnetic particle enzymatic chemiluminescence |
| Modes of Operation | Random, Batch and STAT |
| Separation method | Magnetic separation technology |
| Sample Positions | 60 (Each position could be used as an emergency position) |
| Reagent Positions | 30 pcs (2-8ºC refrigeration) |
| Incubation Positions | 80 |
| Time to 1st Result | 18 Minutes |
| Sample Volume | 15-100ul |
| Detection Precision | CV≤5% |
| Calibration Stability | 28 Days |
| Software system | Windows 7/8/10, 32 or 64 bit; Support HL7 protocol |
| External Size (W*D*H) | 1305*770*1150mm |
| Net Weight | 220Kg |
Our global system includes R&D centers in North Carolina, Kobe, and Stuttgart, alongside a marketing and service network spanning North America, Europe, and Southeast Asia. We specialize in 8 core areas including medical diagnosis, biosafety protection, disinfection, and cold chain products.
Standardized international carton or plywood cases are used for all products. We offer flexible transportation terms including DHL, TNT, EMS, FedEx, and Sea/Air freight options to meet your specific requirements.
